JPS54163578A - Novel imidazole compound and its manufacture - Google Patents

Novel imidazole compound and its manufacture

Info

Publication number
JPS54163578A
JPS54163578A JP1099579A JP1099579A JPS54163578A JP S54163578 A JPS54163578 A JP S54163578A JP 1099579 A JP1099579 A JP 1099579A JP 1099579 A JP1099579 A JP 1099579A JP S54163578 A JPS54163578 A JP S54163578A
Authority
JP
Japan
Prior art keywords
manufacture
imidazole compound
novel imidazole
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1099579A
Other languages
English (en)
Inventor
Geberuto Ururitsuhi
Mujiru Yoozefu
Orutouin Ueeberu Rorufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS54163578A publication Critical patent/JPS54163578A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP1099579A 1975-11-13 1979-02-03 Novel imidazole compound and its manufacture Pending JPS54163578A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550959A DE2550959C3 (de) 1975-11-13 1975-11-13 Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
JPS54163578A true JPS54163578A (en) 1979-12-26

Family

ID=5961645

Family Applications (3)

Application Number Title Priority Date Filing Date
JP51135463A Granted JPS5262278A (en) 1975-11-13 1976-11-12 Production of novel imidazole compound and pharmaceutical agent
JP1099379A Pending JPS5547677A (en) 1975-11-13 1979-02-03 Novel imidazole compound and its manufacture
JP1099579A Pending JPS54163578A (en) 1975-11-13 1979-02-03 Novel imidazole compound and its manufacture

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP51135463A Granted JPS5262278A (en) 1975-11-13 1976-11-12 Production of novel imidazole compound and pharmaceutical agent
JP1099379A Pending JPS5547677A (en) 1975-11-13 1979-02-03 Novel imidazole compound and its manufacture

Country Status (21)

Country Link
US (1) US4152440A (ja)
JP (3) JPS5262278A (ja)
AT (1) AT357155B (ja)
AU (1) AU504009B2 (ja)
BE (1) BE848280A (ja)
CA (1) CA1097350A (ja)
DE (1) DE2550959C3 (ja)
DK (1) DK511376A (ja)
ES (1) ES453276A1 (ja)
FI (1) FI763215A (ja)
FR (1) FR2363328A1 (ja)
GB (1) GB1545939A (ja)
GR (1) GR70648B (ja)
HU (1) HU173879B (ja)
IE (1) IE44184B1 (ja)
IL (1) IL50892A (ja)
LU (1) LU76188A1 (ja)
NL (1) NL7612610A (ja)
NO (1) NO763876L (ja)
SE (1) SE7612685L (ja)
ZA (1) ZA766715B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071866A (en) * 1989-07-31 1991-12-10 Bristol-Myers Squibb Company Arylpyrazole derivatives as anti-platelet agents
US7576221B2 (en) * 2004-06-18 2009-08-18 Novartis Vaccines And Diagnostics, Inc. Substituted imidazole derivatives
CN101622247A (zh) * 2007-01-05 2010-01-06 诺瓦提斯公司 作为驱动蛋白纺锤体蛋白抑制剂的咪唑衍生物
TW200916098A (en) * 2007-06-14 2009-04-16 Teijin Pharma Ltd Agent for lowering uric acid level
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2326631A4 (en) * 2008-08-18 2012-03-21 Univ Yale MODULATORS OF MIF
EP2508511A1 (en) * 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
BE535047A (ja) * 1954-01-21
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
SE7408483L (ja) * 1973-07-27 1975-01-28 Ciba Geigy Ag
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IE44184L (en) 1977-05-13
FI763215A (ja) 1977-05-14
FR2363328B1 (ja) 1979-08-31
DE2550959A1 (de) 1977-05-26
US4152440A (en) 1979-05-01
HU173879B (hu) 1979-09-28
ES453276A1 (es) 1978-02-01
JPS5547677A (en) 1980-04-04
DE2550959C3 (de) 1980-12-04
BE848280A (fr) 1977-05-12
JPS5531155B2 (ja) 1980-08-15
IE44184B1 (en) 1981-09-09
JPS5262278A (en) 1977-05-23
NO763876L (ja) 1977-05-16
FR2363328A1 (fr) 1978-03-31
GB1545939A (en) 1979-05-16
GR70648B (ja) 1982-12-03
IL50892A (en) 1981-02-27
CA1097350A (en) 1981-03-10
IL50892A0 (en) 1977-01-31
DE2550959B2 (de) 1980-04-10
SE7612685L (sv) 1977-05-14
NL7612610A (nl) 1977-05-17
AT357155B (de) 1980-06-25
ZA766715B (en) 1977-10-26
AU504009B2 (en) 1979-09-27
AU1952576A (en) 1978-05-18
DK511376A (da) 1977-05-14
LU76188A1 (ja) 1977-06-06
ATA844476A (de) 1979-11-15

Similar Documents

Publication Publication Date Title
JPS5236783A (en) Semicondutive tape
GB1539006A (en) Aminoalkylammonium compound
JPS5254034A (en) Cosmetic compound
JPS57112389A (en) 1-sulfonylbenzimidazole compound
JPS51140950A (en) Curing compound
MY8100323A (en) Imidazoles
JPS51113900A (en) Riphamycin compound
JPS5277062A (en) Novel imidazole derivatives and composition thereof
JPS5273891A (en) Novel cephalospoline compound
JPS5246068A (en) Production of llleucinee 133mochilin and compound containing the same
JPS51136694A (en) Novel antiibacterial compound
JPS5214726A (en) Process and compound
JPS51138626A (en) Novel compound and preparation thereof
JPS5223076A (en) Antiiinflammatory compound
JPS5253857A (en) Novel oxazolidinee22one compound and preparation thereof
JPS51143699A (en) Riphamycin compound
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
JPS54163578A (en) Novel imidazole compound and its manufacture
JPS5231062A (en) Perfluoroalkylthionorbornane compound
JPS56142292A (en) Novel compound
JPS5231095A (en) Cephlosporin type compound
JPS5278869A (en) Thienylpolyene compound
JPS5257178A (en) Hydantoin compound
KE3118A (en) Imidazoles
JPS5461177A (en) Novel imidazole compound and its manufacture